Ticker: VYCO

Vycor Medical, Inc. (OTCBB: VYCO) reported its quarterly earnings for the period ending June 30, 2025. The company operates with two key segments: Vycor Medical, which focuses on neurosurgical devices, and NovaVision, which offers vision restoration therapies. Key Financial Highlights: Revenue: ...

Vycor Medical, Inc. (OTCBB: VYCO) recently released its quarterly financial results for the period ended March 31, 2025, showing a mixture of positive growth and significant challenges. Key Statistics: Revenue: $436,378 (up 30% from $336,968 in Q1 2024) Gross Profit: $358,534 (up 20% from $299,...